Phio Pharmaceuticals (PHIO) Dividend Coverage Ratio (2012 - 2015)
Phio Pharmaceuticals' (PHIO) quarterly Dividend Coverage Ratio came in at 16.92 in Q1 2015, down 635.15% on a YoY basis from 3.16 in Q1 2014, and down 182.59% quarter-over-quarter from 5.99 in Q4 2014.
Analysis
Phio Pharmaceuticals (PHIO) Dividend Coverage Ratio (2012 - 2015) Analysis & Trends
Phio Pharmaceuticals (PHIO) has reported Dividend Coverage Ratio for 4 consecutive years, with 16.92 the latest figure, recorded in Q1 2015.
- For the quarter ending Q1 2015, Dividend Coverage Ratio fell 635.15% year-over-year to 16.92; the trailing twelve-month figure through Mar 2015 stood at 3.32 (down 58.05% YoY), and the FY2014 full-year result was 3.13, up 8.73% from the prior year.
- Dividend Coverage Ratio retreated to 16.92 in Q1 2015 per PHIO's latest filing, from 5.99 in the prior quarter.
- Across five years, Dividend Coverage Ratio topped out at 2.3 in Q1 2014 and bottomed at 16.92 in Q1 2015.
- Historically, Dividend Coverage Ratio has averaged 6.03 across 4 years, with a median of 4.06 in 2013.
- The sharpest annual moves came in 2014 and 2015: Dividend Coverage Ratio soared 54.51% in 2014, then tumbled 635.15% in 2015.
- Over 4 years, Dividend Coverage Ratio stood at 2.86 in 2012, then slipped by 6.84% to 3.06 in 2013, then plunged by 95.6% to 5.99 in 2014, then sank by 182.59% to 16.92 in 2015.
- According to Business Quant data, Dividend Coverage Ratio over the past three periods registered 16.92, 5.99, and 2.3 for Q1 2015, Q4 2014, and Q1 2014 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 1.74 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -10.18 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 13.40 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Phio Pharmaceuticals | 12.55 Mn | 12.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | -16.92 |
| Dec 31, 2014 | -5.99 |
| Mar 31, 2014 | -2.30 |
| Dec 31, 2013 | -3.06 |
| Mar 31, 2013 | -5.06 |
| Dec 31, 2012 | -2.86 |